Shares of several pharmaceutical companies were up after President Trump signed an executive order aimed at accelerating research, development access to psychedelic medicines for the treatment of ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

If biotech funding continues to increase this year, Danaher could benefit.

We'll know more about the company's medium-term prospects by the end of the year.

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

Replimune has again failed to win regulatory approval for a new drug treating skin cancer, and the result is more than 220 ...

The full picture of Replimune's layoffs is coming into focus — and more employees are on the chopping block than previously ...

Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for Kelonia ...

Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...

The increase in nationwide vacancy to 23.2% is a reversal from the slight dip to end 2025, according to preliminary CBRE data ...